Report Categories
View AllRecent Articles
View All
OPRT Oportun beats Q4 2025 EPS estimates by 103 percent shares gain 191 percent in todays session
How Astrotech ASTC pricing changes flow through to earnings ASTC Q1 2024 Astrotech Swings to 179 Loss on Minimal Revenue
SLXN Silexion Therapeutics posts wider than expected Q4 2025 loss pushing shares 301 percent lower in todays trading
First Trust Natural Gas ETF FCG Positioned to Benefit from Structural European LNG Demand Amid Geopolitical Volatility